Anti-GLR/ GCGR/ GGR monoclonal antibody

Anti-GLR/ GCGR/ GGR antibody for FACS & in-vivo assay

Target products collectionGo to GCGR/GCGR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T60182-Ab-1/ GM-Tg-hg-T60182-Ab-2Anti-Human GCGR monoclonal antibodyHuman
GM-Tg-rg-T60182-Ab-1/ GM-Tg-rg-T60182-Ab-2Anti-Rat GCGR monoclonal antibodyRat
GM-Tg-mg-T60182-Ab-1/ GM-Tg-mg-T60182-Ab-2Anti-Mouse GCGR monoclonal antibodyMouse
GM-Tg-cynog-T60182-Ab-1/ GM-Tg-cynog-T60182-Ab-2Anti-Cynomolgus/ Rhesus macaque GCGR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T60182-Ab-1/ GM-Tg-felg-T60182-Ab-2Anti-Feline GCGR monoclonal antibodyFeline
GM-Tg-cang-T60182-Ab-1/ GM-Tg-cang-T60182-Ab-2Anti-Canine GCGR monoclonal antibodyCanine
GM-Tg-bovg-T60182-Ab-1/ GM-Tg-bovg-T60182-Ab-2Anti-Bovine GCGR monoclonal antibodyBovine
GM-Tg-equg-T60182-Ab-1/ GM-Tg-equg-T60182-Ab-2Anti-Equine GCGR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T60182-Ab-1/ GM-Tg-hg-T60182-Ab-2; GM-Tg-rg-T60182-Ab-1/ GM-Tg-rg-T60182-Ab-2;
GM-Tg-mg-T60182-Ab-1/ GM-Tg-mg-T60182-Ab-2; GM-Tg-cynog-T60182-Ab-1/ GM-Tg-cynog-T60182-Ab-2;
GM-Tg-felg-T60182-Ab-1/ GM-Tg-felg-T60182-Ab-2; GM-Tg-cang-T60182-Ab-1/ GM-Tg-cang-T60182-Ab-2;
GM-Tg-bovg-T60182-Ab-1/ GM-Tg-bovg-T60182-Ab-2; GM-Tg-equg-T60182-Ab-1/ GM-Tg-equg-T60182-Ab-2
Products NameAnti-GCGR monoclonal antibody
Formatmab
Target NameGCGR
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GCGR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-124Pre-Made Crotedumab biosimilar, Whole mAb, Anti-GCGR Antibody: Anti-GGR/GL-R/MVAH therapeutic antibody
    BiosimilarGMP-Bios-INN-857Pre-Made Glucagon Biosimilar, Recombinant Protein targeting GCGR: Recombinant therapeutic protein targeting GGR/GL-R/MVAH
    Target AntigenProducts DevelopingMulti-species GLR/ GCGR/ GGR VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP003748human GCGR Lentivirus plasmid
    ORF Viral VectorvGMLP003748human GCGR Lentivirus particle
    ORF Viral VectorpGMLPm005312mouse Gcgr Lentivirus plasmid
    ORF Viral VectorvGMLPm005312mouse Gcgr Lentivirus particle


    Target information

    Target IDGM-T60182
    Target NameGCGR
    Gene ID2642,14527,24953,714542,483368,101099672,515433,100055316
    Gene Symbol and SynonymsGCGR,GGR,GL-R,GR,MVAH
    Uniprot AccessionP47871,P30082
    Uniprot Entry NameGLR_HUMAN,GLR_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, INN Index
    DiseaseN/A
    Gene EnsemblENSG00000215644
    Target ClassificationGPCR

    The target: GCGR, gene name: GCGR, also named as GGR, GL-R. The protein encoded by this gene is a glucagon receptor that is important in controlling blood glucose levels. Defects in this gene are a cause of non-insulin-dependent diabetes mellitus (NIDDM).[provided by RefSeq, Jan 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.